Now I have a thorough understanding of the paper and can verify the reviewers' claims against the actual text. Let me write the final consolidated review.

---

## Summary

This paper introduces the Sequential Multiple Instance Learning (SMIL) framework, which treats clinical image sequences as ordered (rather than order-independent bags), and proposes BiSMIL — a bidirectional Transformer architecture with a weighted incremental loss function designed to enable accurate early predictions even though only a single bag-level label is available. The authors also propose SMILU, a sequence-aware uncertainty metric. Experiments on three medical imaging datasets (UTD ultrasound, RSNA brain CT, COVID-CT) show that BiSMIL achieves state-of-the-art final accuracy while requiring 30–50% fewer images than baselines to reach comparable performance on subsequence prediction.

---

## Strengths

- **Novel weighted incremental loss for training without subsequence labels (Section 3.3, Eq. 2–4).** The paper's central methodological contribution is a training procedure that uses softmax weights \(w_{il} = e^{(l-m_i)/2}\) to penalize longer subsequences more heavily, so the model learns accurate early predictions despite only the final bag-level label being available. The authors explicitly identify the challenge — "any given subsequence may lack instances that are indicative of positive findings" — and design the loss to address it. This is a principled solution to a real problem that prior MIL methods do not tackle.

- **Consistent state-of-the-art final accuracy across three diverse datasets (Table 1).** BiSMIL achieves the highest accuracy, precision, recall, and F1 on all three datasets (UTD, RSNA, COVID-CT), often with reported statistical significance. The standard deviations over 5 random seeds are reported. Importantly, the bidirectional variant (BiSMIL) outperforms the unidirectional variant (SiSMIL), providing evidence that bidirectionality adds value beyond simply using the ordering.

- **Bidirectional transformer with position encoding as a principled architectural adaptation (Section 3.2).** The architecture combines linear and Gaussian position embeddings and processes sequences in both directions, motivated by the fact that scanning direction varies by clinician. This is a thoughtful design choice grounded in the clinical setting rather than a generic transformer application.

- **SMILU: a sequence-aware uncertainty metric (Section 4).** The metric combines dispersion (standard deviation of incremental predictions) and output uncertainty (weighted successive prediction differences) to capture uncertainty in a way that leverages the sequential structure. The concept is novel and well-motivated for the clinical setting where certainty informs decisions about continuing or terminating a scan.

---

## Weaknesses

### Fatal
None.

### Major

1. **Early prediction accuracy is evaluated against bag-level labels, which the paper itself acknowledges may be incorrect for subsequences.** The headline claim — that BiSMIL achieves comparable accuracy with 30–50% fewer images (Section 5.2, Figure 4) — rests entirely on evaluating subsequence predictions against the bag-level label. The paper acknowledges (Section 3.1): *"It is also insufficient to directly utilize the sequence-level label as a stand-in for the labels of individual subsequences, as any given subsequence may lack instances that are indicative of positive findings."* Yet the evaluation uses exactly this approach without any correction. For positive bags, early subsequences may contain no evidence of the condition, making the bag-level label incorrect for those subsequences. While all methods are compared on the same metric (so relative ordering is meaningful), the absolute interpretation that "30–50% fewer images" translates to clinical efficiency gains is not directly supported. A valid evaluation would require either instance-level labels, a controlled simulation where the ground-truth positive images are known, or at minimum a precision/recall breakdown that accounts for this asymmetry. This is the paper's most significant weakness because it directly affects the most prominent quantitative claim.

2. **Missing a reasonable sequential baseline.** The paper compares BiSMIL only against non-sequential MIL models (ADMIL, MaxPool, SA-DMIL). Since the entire motivation is that sequences have temporal structure, a natural baseline is a simple sequential model (LSTM, GRU, or a vanilla Transformer) that processes the image sequence in order, trained with the same weighted incremental loss. Such a comparison would isolate the benefit of the bidirectional architecture and position encoding over simply using any ordering-aware model. Without it, the observed improvements may partly reflect that *any* sequence-aware model beats bag-level models — a weaker claim than the paper's framing suggests (Section 5.1).

3. **Limited ablation analysis.** The only architectural ablation is removing the reverse direction (SiSMIL vs. BiSMIL). There is no ablation of: (a) the position encoding (removing it or replacing with learned embeddings), (b) the weighted incremental loss (replacing with standard BCE on all subsequences), or (c) the hyperparameter \(\gamma\) (minimum subsequence percentage). Understanding which design choices drive performance is critical for a methods paper, and the current experiments do not disentangle the contributions of the architecture, the loss function, and the bidirectional design. (The garbled reference "datasets.3.2, we demonstrate that the position embedding module is an important driver" on line 186 suggests such an ablation may exist in the original paper but is not cleanly presented; as written, the evidence is insufficient.)

### Minor

1. **SMILU is validated on only one dataset (UTD) against only entropy and random baselines (Figure 3b).** The claim that SMILU "outperforms common metrics" (Section 1) is not supported by the evidence presented. Entropy is a reasonable baseline, but no comparison is made to other standard uncertainty techniques (e.g., Monte Carlo dropout, ensemble variance). The experiment is not replicated on the RSNA or COVID-CT datasets. Additionally, the paper does not report the correlation between SMILU and actual prediction error (e.g., via reliability diagrams), which would strengthen the claim.

2. **No sequential baseline comparison for SMILU.** Since all baselines in Table 1 are non-sequential, it is unclear whether SMILU's benefits are specific to the SMIL framework or would also apply to simpler sequential models.

3. **Feature extractor backbone is underspecified.** The paper mentions "convolutional layers" (Section 3.2) but gives no specific architecture, pretraining source, or input preprocessing details. This hurts reproducibility.

4. **Statistical significance claims are not accompanied by a specified test.** The paper states results are "statistically significant at the 95% level" (Table 1 caption) but does not name the test used (e.g., paired t-test, bootstrap, McNemar). Given the small test sets (particularly COVID-CT with ~42 test patients), this matters.

5. **Patient-level vs. slice-level splits are not explicitly stated.** For the RSNA dataset (50,862 slices from 1,175 patients), it is critical to confirm that all splits are at the patient level to prevent leakage. The paper implies this ("each patient with... scans forming a sequence") but never states it explicitly.

6. **Loss weighting hyperparameters \(\alpha=\beta=0.5\) are reported without sensitivity analysis** (Section 3.3). The decay rate for the softmax weights (factor \(e^{(l-m_i)/2}\)) is also used in SMILU without explicit justification for this specific choice.

### Trivial

- The paper does not justify the specific exponential decay rate (factor 1/2) used in both the weighted incremental loss and SMILU (Sections 3.3, 4.1).
- The COVID-CT test set is small (~42 patients), so the standard deviations in Table 1 for this dataset should be interpreted with caution.

---

## Nice-to-Haves

- Validating SMILU on all three datasets and against at least one additional uncertainty baseline (e.g., MC dropout).
- Providing reliability diagrams or ECE calibration curves for SMILU.
- Conducting a controlled simulation where ground-truth positive images are known, to provide a gold-standard evaluation of early prediction accuracy.
- Ablating the position encoding (remove it entirely; replace with learned embeddings).
- Ablating the weighted incremental loss (replace with standard BCE on all subsequences).
- Reporting the specific statistical test used for significance claims and showing confidence intervals directly in Table 1.

---

## Removed Points

*These points are flagged to be removed; treat them with caution.*

- **Strength: "Superior early prediction accuracy with 30–50% fewer instances"** — Removed because it conflicts with verified Weakness #1 (evaluation uses bag-level labels as ground truth for subsequences, which the paper acknowledges may be incorrect).
- **Strength: "SMILU uncertainty metric outperforms entropy"** — Removed because it conflicts with verified Minor Weakness #1 (SMILU is validated on only one dataset against only entropy and random; the claim of "outperformance" is not sufficiently supported).
- **Criticism: "Related work section too brief; should discuss sequential modeling in other domains"** — Removed per policy (DO NOT mention missing related works, as external sources cannot be confirmed).
- **Criticism: "No code release mentioned"** — Removed per policy (nitpick about reproducibility artifacts not practical to include in a submission).
- **Criticism: "Ethical considerations about dataset demographics"** — Removed as scope creep for a methods paper; the datasets are described with acquisition details.
- **Criticism: "The position encoding Gaussian component motivation is hand-waved"** — Demoted from standalone weakness; it is a Trivial-level observation subsumed by the broader lack of ablation analysis (Major Weakness #3).

---

## Novel Insights

Neither reviewer identifies an insight that goes beyond the paper's own contributions. The reviews surface standard concerns (evaluation validity, missing baselines, ablation gaps) that are typical for a new framework paper but do not reframe or deepen the contribution itself. The most interesting observation — that the paper's training procedure acknowledges the subsequence-label problem but then evaluates against the same flawed labels — is essentially a restatement of the paper's own stated limitation, not a novel synthesis.

---

## Suggestions

1. **Address the early prediction evaluation gap.** The most direct path is to construct a controlled simulation where the ground-truth "positive" images are known (e.g., inject synthetic lesions into known-clear images at known positions). This would allow computing precision/recall of early predictions against the true state of the subsequence. Alternatively, if such a dataset exists, report instance-level labels. Without this, the 30–50% reduction claim remains suggestive but not conclusive.

2. **Add at least one sequential baseline.** An LSTM or unidirectional Transformer trained with the same weighted incremental loss would provide the most direct comparison to isolate the benefit of BiSMIL's bidirectional architecture and position encoding over any ordering-aware model.

3. **Perform the missing ablations** on at least the UTD dataset: (a) remove position encoding, (b) use learned position embeddings, (c) replace weighted incremental loss with standard BCE on all subsequences, (d) vary \(\gamma\). Report which components drive the early prediction gains.

4. **Validate SMILU on at least one additional dataset** and against at least one more uncertainty baseline (MC dropout is the most natural choice). Report the correlation between SMILU and actual prediction error.

5. **Explicitly state** that all data splits are at the patient level, name the statistical test used for significance claims, and specify the feature extractor backbone and pretraining details.

---

## Score and Decision

The paper addresses a genuine and under-explored problem (sequential MIL for clinical imaging) and proposes a method (BiSMIL + weighted incremental loss) that is well-motivated, thoughtful in its design, and achieves strong final accuracy across three datasets. The weaknesses are real but not fatal: the early prediction evaluation issue weakens the headline quantitative claim but does not invalidate the relative comparisons, and the missing baseline and ablations are addressable. The core methodological contribution — training a sequential model to make accurate early predictions without subsequence labels — is novel and clearly presented.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Weak Accept</decision>